81 related articles for article (PubMed ID: 22902670)
1. Influence of methamphetamine on genital herpes simplex virus type 2 infection in a mouse model.
Valencia F; Bubar MJ; Milligan G; Cunningham KA; Bourne N
Sex Transm Dis; 2012 Sep; 39(9):720-5. PubMed ID: 22902670
[TBL] [Abstract][Full Text] [Related]
2. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
[TBL] [Abstract][Full Text] [Related]
3. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract.
Gallichan WS; Rosenthal KL
Virology; 1996 Oct; 224(2):487-97. PubMed ID: 8874509
[TBL] [Abstract][Full Text] [Related]
4. 3,4-Methylenedioxymethamphetamine increases susceptibility to genital herpes simplex virus infection in mice.
Pennock JW; Stegall R; Bubar MJ; Milligan G; Cunningham KA; Bourne N
J Infect Dis; 2009 Oct; 200(8):1247-50. PubMed ID: 19758099
[TBL] [Abstract][Full Text] [Related]
5. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
6. Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?
Bollen LJ; Whitehead SJ; Mock PA; Leelawiwat W; Asavapiriyanont S; Chalermchockchareonkit A; Vanprapar N; Chotpitayasunondh T; McNicholl JM; Tappero JW; Shaffer N; Chuachoowong R
AIDS; 2008 Jun; 22(10):1169-76. PubMed ID: 18525263
[TBL] [Abstract][Full Text] [Related]
7. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
Wizel B; Persson J; Thörn K; Nagy E; Harandi AM
Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292
[TBL] [Abstract][Full Text] [Related]
8. Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in mice.
Tengvall S; Harandi AM
J Reprod Immunol; 2008 Jun; 78(1):49-57. PubMed ID: 17945349
[TBL] [Abstract][Full Text] [Related]
9. Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation.
Gillgrass AE; Fernandez SA; Rosenthal KL; Kaushic C
J Virol; 2005 Mar; 79(5):3107-16. PubMed ID: 15709030
[TBL] [Abstract][Full Text] [Related]
10. Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection.
John M; Keller MJ; Fam EH; Cheshenko N; Hogarty K; Kasowitz A; Wallenstein S; Carlucci MJ; Tuyama AC; Lu W; Klotman ME; Lehrer RI; Herold BC
J Infect Dis; 2005 Nov; 192(10):1731-40. PubMed ID: 16235171
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.
Fotouhi F; Soleimanjahi H; Roostaee MH; Behzadian F
FEMS Immunol Med Microbiol; 2008 Oct; 54(1):18-26. PubMed ID: 18647350
[TBL] [Abstract][Full Text] [Related]
12. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
Tengvall S; O'Hagan D; Harandi AM
Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
[TBL] [Abstract][Full Text] [Related]
13. Impaired induction of protective immunity by highly virulent herpes simplex virus type 2 in a murine model of genital herpes.
Inagaki-Ohara K; Daikoku T; Goshima F; Nishiyama Y
Arch Virol; 2000; 145(10):1989-2002. PubMed ID: 11087087
[TBL] [Abstract][Full Text] [Related]
14. A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes.
Zeitlin L; Olmsted SS; Moench TR; Co MS; Martinell BJ; Paradkar VM; Russell DR; Queen C; Cone RA; Whaley KJ
Nat Biotechnol; 1998 Dec; 16(13):1361-4. PubMed ID: 9853620
[TBL] [Abstract][Full Text] [Related]
15. Decreased vaginal disease in J-chain-deficient mice following herpes simplex type 2 genital infection.
Hendrickson BA; Guo J; Brown I; Dennis K; Marcellino D; Hetzel J; Herold BC
Virology; 2000 May; 271(1):155-62. PubMed ID: 10814580
[TBL] [Abstract][Full Text] [Related]
16. Innate immunity to herpes simplex virus type 2.
Duerst RJ; Morrison LA
Viral Immunol; 2003; 16(4):475-90. PubMed ID: 14733735
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity.
Harandi AM; Svennerholm B; Holmgren J; Eriksson K
J Virol; 2001 Jul; 75(14):6705-9. PubMed ID: 11413339
[TBL] [Abstract][Full Text] [Related]
18. IL-36γ induces a transient HSV-2 resistant environment that protects against genital disease and pathogenesis.
Gardner JK; Herbst-Kralovetz MM
Cytokine; 2018 Nov; 111():63-71. PubMed ID: 30118914
[TBL] [Abstract][Full Text] [Related]
19. Parameters of CpG oligodeoxynucleotide-induced protection against intravaginal HSV-2 challenge.
Sajic D; Ashkar AA; Patrick AJ; McCluskie MJ; Davis HL; Levine KL; Holl R; Rosenthal KL
J Med Virol; 2003 Dec; 71(4):561-8. PubMed ID: 14556270
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus 2-induced activation in vaginal cells involves Toll-like receptors 2 and 9 and DNA sensors DAI and IFI16.
Triantafilou K; Eryilmazlar D; Triantafilou M
Am J Obstet Gynecol; 2014 Feb; 210(2):122.e1-122.e10. PubMed ID: 24080302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
